Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY-NC-NDInternal Medicine

Clinical Significance of Pasteurella multocida Sputum Isolates in Structural Lung Disease: A Case Series

Abstract

Objective To determine the clinical significance of sputum Pasteurella multocida in adults with structural lung disease by operationally distinguishing infection from colonization and describing outcomes of pathogen-directed therapy. Methods We performed a single-center, retrospective case study. Infection was defined a priori by new or worsening lower-respiratory symptoms at the time of culture, supported by inflammatory or radiologic changes; isolation without symptoms was classified as colonization. Two pulmonologists blinded to the clinical data reviewed the chest computed tomography scans. Antibiotic selection and clinical responses within 2-4 weeks were extracted from the charts. Results Seven adults (five women; mean age, 67.1 years) with structural airway disease were included. Middle lobe syndrome and diffuse panbronchiolitis were predominant, while bronchiectasis was present in two patients. Five of the seven patients (71.4%) reported regular dog/cat exposure. Sputum cultures were obtained for acute symptom exacerbations in four patients and for incidental imaging abnormalities in three. Three symptomatic patients received penicillin-class therapy and all improved. One symptomatic patient improved without antibiotics. No recent animal bites or scratches were reported. No severe treatment-related adverse events were observed. Conclusion In elderly patients with structural airway disease, sputum P. multocida during symptomatic episodes likely represents true infection and responds to targeted narrow-spectrum therapy, whereas asymptomatic isolates may reflect colonization. These observations provide a pragmatic framework to distinguish infection from colonization, support susceptibility-aligned narrow-spectrum management, and offer small-series evidence to inform antimicrobial stewardship in structural lung diseases.

Related

  1. Heterologous expression of the membrane protein OmpA from bovine Pasteurella multocida and establishment of an indirect ELISA for antibody detection
    Donghao Hao, Sie Han, Yan Wang +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMicrobiologyCrossref
  2. Pathogenicity and Comparative Genomics Analysis: Pasteurella multocida Serogroups A and F Isolated from Domestic Rabbits in China.
    Qiaoya Zhao, Cunxia Liu, Xiuli Ma +7
    Veterinary sciencesPeer-reviewedCC BYFull textMicrobiologyEurope PMC
  3. Large-scale exposure of southern seabirds to avian cholera Pasteurella multocida: scavengers as sentinels at different spatial scales
    J. Tornos, A. gamble, A. Clessin +25
    bioRxivPreprintCC BY-NDFull textEcologybioRxiv
  4. Characterization of Outer Membrane β-barrel Proteins of Pasteurella multocida for Multi-Epitope Vaccine Design against Human Pasteurellosis
    A. Panda, J. Kapoor, S. Kumar +1
    bioRxivPreprintCC BY-NDFull textBioinformatics & computational biologybioRxiv
  5. Isolation, antibiogram and whole genome sequence analysis of Pasteurella multocida type A from layer birds
    Md Ahosanul Haque Shahid, Ajran Kabir, Shanta Das +2
    PLOS OnePeer-reviewedCC BY 4.0Full textEnzymology & metabolismEvolutionary biologyPLOS
BibTeX
@article{kawasaki2026clinical,
  title = {{Clinical Significance of Pasteurella multocida Sputum Isolates in Structural Lung Disease: A Case Series}},
  author = {Hiroya Kawasaki and Kazunori Tobino},
  journal = {Internal Medicine},
  year = {2026},
  month = aug,
  doi = {10.2169/internalmedicine.6421-25},
  url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/15/65_6421-25/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Clinical Significance of Pasteurella multocida Sputum Isolates in Structural Lung Disease: A Case Series
AU  - Hiroya Kawasaki
AU  - Kazunori Tobino
PY  - 2026
DA  - 2026/08/01
JO  - Internal Medicine
DO  - 10.2169/internalmedicine.6421-25
UR  - https://www.jstage.jst.go.jp/article/internalmedicine/65/15/65_6421-25/_article
AB  - Objective To determine the clinical significance of sputum Pasteurella multocida in adults with structural lung disease by operationally distinguishing infection from colonization and describing outcomes of pathogen-directed therapy. Methods We performed a single-center, retrospective case study. Infection was defined a priori by new or worsening lower-respiratory symptoms at the time of culture, supported by inflammatory or radiologic changes; isolation without symptoms was classified as colonization. Two pulmonologists blinded to the clinical data reviewed the chest computed tomography scans. Antibiotic selection and clinical responses within 2-4 weeks were extracted from the charts. Results Seven adults (five women; mean age, 67.1 years) with structural airway disease were included. Middle lobe syndrome and diffuse panbronchiolitis were predominant, while bronchiectasis was present in two patients. Five of the seven patients (71.4%) reported regular dog/cat exposure. Sputum cultures were obtained for acute symptom exacerbations in four patients and for incidental imaging abnormalities in three. Three symptomatic patients received penicillin-class therapy and all improved. One symptomatic patient improved without antibiotics. No recent animal bites or scratches were reported. No severe treatment-related adverse events were observed. Conclusion In elderly patients with structural airway disease, sputum P. multocida during symptomatic episodes likely represents true infection and responds to targeted narrow-spectrum therapy, whereas asymptomatic isolates may reflect colonization. These observations provide a pragmatic framework to distinguish infection from colonization, support susceptibility-aligned narrow-spectrum management, and offer small-series evidence to inform antimicrobial stewardship in structural lung diseases.
SN  - 1349-7235
SN  - 0918-2918
ER  -